Estadermal® (Estradiol) Transdermal Patch — Hormone Replacement Therapy for Menopause

Gold Standard Transdermal Estrogen Therapy for Menopausal Symptom Relief and Osteoporosis Prevention

Estadermal® (Estradiol Transdermal Patch) is a transdermal hormone replacement therapy (HRT) delivering 17β-estradiol — the primary and most potent naturally occurring oestrogen — continuously through the skin. Estadermal is used to treat moderate to severe vasomotor symptoms of menopause, vulvar and vaginal atrophy, hypoestrogenism, and prevention of postmenopausal osteoporosis. The transdermal route avoids first-pass hepatic metabolism — providing consistent estradiol levels with a more favourable safety profile compared to oral estrogen therapy.

A.K. Pharma is a trusted medicine distributor in Delhi supplying genuine Estadermal Patch (Estradiol) to hospitals, gynaecology clinics, menopause centres, and pharmacies across India. Manufactured by leading pharmaceutical companies, Estadermal is one of the most widely used transdermal HRT preparations globally.

What is Estadermal Patch (Estradiol)?

Estadermal contains 17β-estradiol — bioidentical to the oestrogen naturally produced by the ovaries — delivered via a transdermal drug delivery system. The patch contains estradiol in a polymer matrix or reservoir system that controls the rate of drug release through the skin into the systemic circulation.

The transdermal delivery system provides several pharmacokinetic advantages over oral estrogen:

• Avoids first-pass hepatic metabolism — delivering estradiol directly into the systemic circulation
• Provides stable, continuous estradiol levels — avoiding the peaks and troughs of oral therapy
• Bypasses the gut — reducing GI side effects
• Lower doses achieve therapeutic plasma levels compared to oral preparations
• Does not increase hepatic production of clotting factors, triglycerides, and CRP — key safety advantage

Full prescribing information is available at the FDA label for Estradiol Transdermal.

Clinical Studies and Evidence

WHI Study — Lessons Learned (Oral vs Transdermal HRT) The Women’s Health Initiative (WHI) study raised concerns about oral combined HRT. However subsequent analyses and observational studies have demonstrated that transdermal estradiol has a significantly more favourable safety profile — particularly regarding venous thromboembolism (VTE) risk. Published in Circulation (2010), studies show transdermal estradiol does not increase VTE risk unlike oral estrogens.

KEEPS Trial (Kronos Early Estrogen Prevention Study) The KEEPS trial evaluated transdermal estradiol in early menopause — demonstrating significant improvements in menopausal symptoms, mood, and quality of life without adverse cardiovascular effects in recently menopausal women.

Osteoporosis Prevention Studies Multiple randomised controlled trials demonstrate transdermal estradiol significantly prevents bone loss in postmenopausal women — maintaining or increasing bone mineral density at the spine and hip and reducing fracture risk.

Vasomotor Symptom Studies Numerous trials demonstrate transdermal estradiol effectively reduces hot flush frequency and severity by 70-90% compared to placebo — providing significant symptom relief for menopausal women.

E3N Cohort Study (Breast Cancer Risk) Published in the International Journal of Cancer (2008), the E3N cohort study demonstrated that transdermal estradiol combined with micronised progesterone does not increase breast cancer risk — unlike oral combined HRT — supporting the preferential use of transdermal HRT with bioidentical progesterone.

Available Strengths

Estadermal is available in the following strengths:

Treatment is typically started at the lowest effective dose — usually 50mcg/24h — and adjusted based on symptom control and tolerability. Patches are applied to clean, dry, intact skin on the lower abdomen, buttocks, or upper thigh.

Indications — What Estadermal is Used For

Menopausal Hormone Therapy (MHT):

• Treatment of moderate to severe vasomotor symptoms of menopause — hot flushes, night sweats
• Treatment of vulvar and vaginal atrophy associated with menopause
• Treatment of moderate to severe symptoms of genitourinary syndrome of menopause (GSM)

Hypoestrogenism:

• Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian insufficiency
• Female hypogonadism — delayed puberty, premature ovarian insufficiency

Osteoporosis Prevention:

• Prevention of postmenopausal osteoporosis — in women at significant risk

Note: Women with an intact uterus must use estrogen in combination with a progestogen to prevent endometrial hyperplasia and carcinoma. Women who have had a hysterectomy may use estrogen alone.

For detailed indication information refer to MedlinePlus Estradiol Transdermal.

Key Benefits of Estadermal

Avoids First-Pass Hepatic Metabolism Transdermal delivery bypasses the liver — unlike oral estrogens which undergo significant hepatic first-pass metabolism. This avoids the hepatic stimulation responsible for increased coagulation factors, triglycerides, and C-reactive protein — the mechanisms underlying oral HRT’s cardiovascular and VTE risks.

Lower VTE Risk Than Oral Estrogens Multiple observational studies demonstrate transdermal estradiol does not significantly increase VTE risk — unlike oral estrogens — making Estadermal the preferred HRT formulation in women with cardiovascular risk factors or VTE history.

Stable Continuous Estradiol Levels Continuous transdermal delivery provides stable plasma estradiol levels — avoiding the peaks and troughs of oral therapy — resulting in more consistent symptom control and fewer side effects.

Highly Effective for Vasomotor Symptoms Estadermal reduces hot flush frequency and severity by 70-90% — providing significant relief from the most common and distressing menopausal symptoms.

Prevents Postmenopausal Bone Loss Estrogen is the most effective agent for preventing postmenopausal bone loss — Estadermal maintains and increases bone mineral density at the spine and hip, reducing fracture risk.

Convenient Application Twice weekly or weekly patch application is significantly more convenient than daily oral tablets — improving adherence and treatment persistence.

How Estadermal Works

Estrogen plays a critical role in multiple physiological systems. During and after menopause, declining ovarian estrogen production leads to:

• Vasomotor symptoms — hot flushes and night sweats due to hypothalamic thermoregulatory dysfunction
• Urogenital atrophy — thinning and dryness of vaginal and urethral tissues
• Bone loss — accelerated due to loss of estrogen’s bone-protective effects
• Mood changes — due to estrogen’s effects on neurotransmitter systems
• Cardiovascular changes — adverse lipid profile changes, endothelial dysfunction

Estadermal works by:

• Delivering bioidentical 17β-estradiol through the skin into the systemic circulation
• Estradiol binds to nuclear estrogen receptors (ERα and ERβ) in target tissues
• Activates estrogen-responsive genes — regulating multiple physiological processes
• Restores hypothalamic thermoregulatory function — reducing vasomotor symptoms
• Maintains vaginal and urethral epithelial integrity — treating urogenital atrophy
• Inhibits osteoclast activity — preserving bone mineral density
• Maintains favourable lipid profile and endothelial function

For a detailed overview refer to the British Menopause Society guidelines and International Menopause Society recommendations.

Estadermal vs Oral Estrogen — Key Differences

Dosage and Administration

Starting Dose:

• Estadermal 50 (50mcg/24h) — standard starting dose for most indications
• Estadermal 25 (25mcg/24h) — for sensitive patients or lower dose requirements
• Estadermal 100 (100mcg/24h) — for inadequate symptom control on 50mcg

Application:

• Apply to clean, dry, intact, non-irritated skin on lower abdomen, buttocks, or upper thigh
• Avoid breasts, waistline, and irritated or damaged skin
• Press firmly for 30 seconds — ensure complete adhesion
• Rotate application sites — avoid same site within 1 week
• Apply immediately after opening pouch

Frequency:

• Twice weekly (every 3-4 days) or weekly — depending on specific product formulation

Progestogen Co-administration:

• Women with intact uterus must add a progestogen for at least 12-14 days per month (sequential) or continuously
• Women post-hysterectomy may use estrogen alone

Full dosing guidelines available at Drugs.com Estradiol Transdermal Dosage.

Who Should Use Estadermal

Estadermal is prescribed for:

• Perimenopausal and postmenopausal women with moderate to severe vasomotor symptoms
• Women with premature ovarian insufficiency or surgical menopause
• Women with urogenital atrophy or genitourinary syndrome of menopause
• Women at risk of postmenopausal osteoporosis
• Women with cardiovascular risk factors where transdermal HRT is preferred over oral
• Women who have experienced VTE where HRT is still indicated — transdermal preferred

Estadermal is prescribed by gynaecologists, endocrinologists, and general physicians. A.K. Pharma supplies Estadermal to hospitals, gynaecology clinics, and pharmacies across Delhi and India.

Possible Side Effects

Common side effects include application site reactions (redness, irritation, itching), breast tenderness, headache, nausea, and breakthrough bleeding (when used with progestogen).

Serious side effects include:

• Endometrial hyperplasia/carcinoma — risk with estrogen alone in women with intact uterus — always add progestogen
• Breast cancer — long-term HRT use may slightly increase risk — individualise benefit-risk assessment
• VTE — lower risk with transdermal vs oral but still monitor in high-risk women
• Cardiovascular events — initiate HRT close to menopause (timing hypothesis) for cardiovascular benefit
• Stroke — risk may be increased particularly with oral HRT

Full side effect information available at FDA Estradiol Transdermal Safety Information.

Precautions and Contraindications

Estadermal is contraindicated in:

• Undiagnosed abnormal genital bleeding
• Known, suspected, or history of breast cancer
• Known or suspected estrogen-dependent malignant tumours
• Active or previous arterial thromboembolic disease (stroke, MI)
• Active or recent VTE (DVT, PE) — unless already on anticoagulants
• Active liver disease or liver function impairment
• Porphyria cutanea tarda
• Pregnancy and breastfeeding

Additional precautions:

• Endometrial assessment before initiating — investigate abnormal bleeding
• Women with intact uterus must always use progestogen with estrogen
• Annual gynaecological review during HRT
• Mammography screening as per national guidelines
• Rotate application sites to minimise skin reactions
• Refer to WHO Menopause Health Guidelines for broader context

Storage and Handling

• Store at room temperature below 25°C
• Keep in original sealed pouch until use
• Do not store above 25°C or in direct sunlight
• Keep out of reach of children and pets
• After removal fold patch adhesive side inward and dispose safely — residual estradiol remains in used patches

As a responsible medicine distributor in Delhi, A.K. Pharma stores all medicines including Estadermal under manufacturer-recommended conditions ensuring product integrity for every supply.

Manufacturer Information

Estadermal (Estradiol Transdermal Patch) is manufactured by leading pharmaceutical companies including Novartis and other generic manufacturers. The originator Estraderm was developed by Novartis. A.K. Pharma supplies only genuine Estadermal sourced from authorized distributors.

Related Hormone Medicines Available at A.K. Pharma

• Menopur (Menotrophin) — gonadotropin for IVF and fertility treatment
• Genotropin (Somatropin) — recombinant human growth hormone
• Zoladex (Goserelin) — GnRH agonist for hormone-sensitive conditions
• Firmagon (Degarelix) — GnRH antagonist for prostate cancer
• Browse all Hormone Medicines available at A.K. Pharma

Frequently Asked Questions

Q. What is Estadermal Patch used for? Estadermal Patch (Estradiol) is used for hormone replacement therapy in menopausal women — treating hot flushes, night sweats, vaginal dryness, and preventing postmenopausal osteoporosis. More information available at MedlinePlus.

Q. What is the generic name of Estadermal? The generic name of Estadermal is Estradiol — specifically 17β-estradiol, bioidentical to the oestrogen naturally produced by the ovaries.

Q. Is transdermal HRT safer than oral HRT? Multiple studies demonstrate transdermal estradiol has a significantly more favourable safety profile than oral estrogens — particularly regarding VTE risk. Transdermal estradiol does not significantly increase VTE risk unlike oral estrogens which increase risk 2-4 fold. The E3N cohort study also suggests transdermal estradiol with bioidentical progesterone does not increase breast cancer risk unlike oral combined HRT.

Q. Do I need to take a progestogen with Estadermal? Women with an intact uterus must always use a progestogen alongside estrogen therapy to protect the endometrium from hyperplasia. Women who have had a hysterectomy may use estrogen alone without progestogen.

Q. Is Estadermal available in India? Estadermal can be supplied to hospitals, gynaecology clinics, and pharmacies across India through licensed pharmaceutical distributors. Contact A.K. Pharma — medicine distributor in Delhi — for availability and pricing.

Q. What is the price of Estadermal Patch in India? Estadermal price in India varies by strength and pack size. Contact A.K. Pharma at 011 4172 6999 or WhatsApp +91 9810034827 for current pricing and bulk supply rates.

Q. How to order Estadermal from A.K. Pharma? You can request a quote directly from this page, call us at 011 4172 6999, or WhatsApp us at +91 9810034827 with your requirements and we will respond promptly.

Q. Does A.K. Pharma supply Estadermal in bulk? Yes. A.K. Pharma supplies Estadermal in bulk to hospitals, gynaecology clinics, and pharmacies across Delhi and India. Contact us for bulk pricing and availability.

Why Order Estadermal from A.K. Pharma?

• Licensed medicine distributor in Delhi with all required drug licenses
• 100% genuine Estadermal sourced from authorized distributors
• Reliable supply to gynaecology clinics, hospitals, and pharmacies across India
• Bulk supply available with competitive pricing
• Prompt response to all quote requests
• Serving gynaecologists and endocrinologists across Delhi NCR and India

Contact A.K. Pharma for Estadermal Supply 📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052 📞 011 4172 6999 📱 WhatsApp: +91 9810034827 🌐 akpharma.in